help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sjoberg, A.
Right arrow Articles by Olofsson, S. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sjoberg, A.
Right arrow Articles by Olofsson, S. O.

Endocrinology, Vol 130, 3356-3364, Copyright © 1992 by Endocrine Society


ARTICLES

Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver

A Sjoberg, J Oscarsson, K Bostrom, TL Innerarity, S Eden and SO Olofsson
Department of Medical Biochemistry, University of Goteborg, Sweden.

Apolipoprotein-B 48 (apoB 48) and apoB 100 expression and the editing of apoB mRNA have previously been shown to be hormonally regulated in rat liver. We have investigated the effects of hypophysectomy and replacement therapy with T4, cortisol (C), and GH in vivo on the proportion of edited apoB mRNA in rat liver and cultured rat hepatocytes as well as the synthesis and secretion of apoB 48 and apoB 100 in cultured rat hepatocytes. Hypophysectomy decreased the proportion of edited apoB mRNA in intact liver from 62% in normal rats to 29% in hypophysectomized rats. Treatment of hypophysectomized rats with T4 and C did not influence the proportion of edited apoB mRNA, whereas treatment with GH, either alone or together with T4 and C, increased the proportion of edited apoB mRNA to the levels observed in normal rats. In cultured hepatocytes isolated from normal rats, the proportion of apoB 48 (percentage of total labeled apoB) was 78% and decreased to 40% in cells isolated from hypophysectomized rats. Treatment of hypophysectomized rats with T4 and C had no effect on the proportion of apoB 48 present in isolated cells, whereas it increased to 60% after treatment with GH together with T4 and C. The proportion of apoB 48 in the medium was affected by hypophysectomy and the various hormonal treatments in a similar way to that observed in the cells. Results from in vivo labeling experiments suggested that GH alone had the capacity to increase the percentage of apoB 48 in hypophysectomized rats. On the contrary, T4 and C was needed, in addition to GH, to increase the proportion of apoB 48 in isolated hepatocytes from hypophysectomized rats. Our results suggest that this discrepancy is due to a difference between the effect of GH alone on apoB mRNA editing in the intact liver and that in isolated hepatocytes. The total secretion of apoB into the cell culture medium was not affected by hypophysectomy and hormonal treatments of the rats. In conclusion, these results indicate that GH is involved in the regulation of editing of apoB mRNA and the proportion of apoB 48 synthesized and secreted in rat liver. Thus, our observations emphasize the importance of GH as a regulator of lipoprotein metabolism.


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
U. Edvardsson, A. Ljungberg, D. Linden, L. William-Olsson, H. Peilot-Sjogren, A. Ahnmark, and J. Oscarsson
PPAR{alpha} activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes
J. Lipid Res., February 1, 2006; 47(2): 329 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Ameen, U. Edvardsson, A. Ljungberg, L. Asp, P. Akerblad, A. Tuneld, S.-O. Olofsson, D. Linden, and J. Oscarsson
Activation of Peroxisome Proliferator-activated Receptor {alpha} Increases the Expression and Activity of Microsomal Triglyceride Transfer Protein in the Liver
J. Biol. Chem., January 14, 2005; 280(2): 1224 - 1229.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. Stillemark-Billton, C. Beck, J. Boren, and S.-O. Olofsson
Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2
J. Lipid Res., January 1, 2005; 46(1): 104 - 114.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Endocr. Rev., February 1, 2004; 25(1): 102 - 152.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Lind, M. Rudling, S. Ericsson, H. Olivecrona, M. Eriksson, B. Borgstrom, G. Eggertsen, L. Berglund, and B. Angelin
Growth Hormone Induces Low-Density Lipoprotein Clearance but not Bile Acid Synthesis in Humans
Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 349 - 356.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Ameen and J. Oscarsson
Sex Difference in Hepatic Microsomal Triglyceride Transfer Protein Expression Is Determined by the Growth Hormone Secretory Pattern in the Rat
Endocrinology, September 1, 2003; 144(9): 3914 - 3921.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Patterson, Z. Chen, D. C. Rubin, V. Moucadel, J. L. Iovanna, H. B. Brewer Jr., and T. L. Eggerman
Developmental Regulation of Apolipoprotein B mRNA Editing Is an Autonomous Function of Small Intestine Involving Homeobox Gene Cdx1
J. Biol. Chem., February 21, 2003; 278(9): 7600 - 7606.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Jalouli, L. Carlsson, C. Ameen, D. Linden, A. Ljungberg, L. Michalik, S. Eden, W. Wahli, and J. Oscarsson
Sex Difference in Hepatic Peroxisome Proliferator-Activated Receptor {alpha} Expression: Influence of Pituitary and Gonadal Hormones
Endocrinology, January 1, 2003; 144(1): 101 - 109.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Frick, D. Linden, C. Ameen, S. Eden, A. Mode, and J. Oscarsson
Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat
Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1023 - E1031.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Frick, M. Bohlooly-Y, D. Linden, B. Olsson, J. Tornell, S. Eden, and J. Oscarsson
Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1230 - E1239.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. Linden, M. Alsterholm, H. Wennbo, and J. Oscarsson
PPAR{alpha} deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins
J. Lipid Res., November 1, 2001; 42(11): 1831 - 1840.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Carlsson, D. Linden, M. Jalouli, and J. Oscarsson
Effects of fatty acids and growth hormone on liver fatty acid binding protein and PPAR{alpha} in rat liver
Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E772 - E781.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. RUDLING and B. ANGELIN
Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice
FASEB J, June 1, 2001; 15(8): 1350 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Oscarsson, C. Gardmo, S. Eden, and A. Mode
Pulsatile growth hormone secretion decreases S-adenosylmethionine synthetase in rat liver
Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E280 - E286.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Linden, A. Sjoberg, L. Asp, L. Carlsson, and J. Oscarsson
Direct effects of growth hormone on production and secretion of apolipoprotein B from rat hepatocytes
Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1335 - E1346.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. Levy, J.-F. Beaulieu, E. Delvin, E. Seidman, W. Yotov, J.-R. Basque, and D. Ménard
Human crypt intestinal epithelial cells are capable of lipid production, apolipoprotein synthesis, and lipoprotein assembly
J. Lipid Res., January 1, 2000; 41(1): 12 - 22.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Svensson, J.-O. Jansson, M. Ottosson, G. Johannsson, M.-R. Taskinen, O. Wiklund, and B.-A. Bengtsson
Treatment of Obese Subjects with the Oral Growth Hormone Secretagogue MK-677 Affects Serum Concentrations of Several Lipoproteins, But Not Lipoprotein(a)
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2028 - 2033.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Leonsson, J. Oscarsson, I. Bosaeus, B. K. Lundgren, G. Johannsson, O. Wiklund, and B. A. Bengtsson
Growth Hormone (GH) Therapy in GH-Deficient Adults Influences the Response to a Dietary Load of Cholesterol and Saturated Fat in Terms of Cholesterol Synthesis, But Not Serum Low Density Lipoprotein Cholesterol Levels
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1296 - 1303.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Parini, B. Angelin, and M. Rudling
Cholesterol and Lipoprotein Metabolism in Aging : Reversal of Hypercholesterolemia by Growth Hormone Treatment in Old Rats
Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 832 - 839.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Greeve, D. Axelos, S. Welker, M. Schipper, and H. Greten
Distinct Promoters Induce APOBEC-1 Expression in Rat Liver and Intestine
Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1079 - 1092.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Carlsson, I. Nilsson, and J. Oscarsson
Hormonal Regulation of Liver Fatty Acid-Binding Protein in Vivo and in Vitro: Effects of Growth Hormone and Insulin
Endocrinology, June 1, 1998; 139(6): 2699 - 2709.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. P. Ceda, E. Dall’Aglio, A. Magnacavallo, N. Vargas, V. Fontana, M. Maggio, G. Valenti, P. D. K. Lee, R. L. Hintz, and A. R. Hoffman
The Insulin-Like Growth Factor Axis and Plasma Lipid Levels in the Elderly
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 499 - 502.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. L. Innerarity, J. Borén, S. Yamanaka, and S.-O. Olofsson
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
J. Biol. Chem., February 2, 1996; 271(5): 2353 - 2356.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C.-N. Wang, R. S. McLeod, Z. Yao, and D. N. Brindley
Effects of Dexamethasone on the Synthesis, Degradation, and Secretion of Apolipoprotein B in Cultured Rat Hepatocytes
Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1481 - 1491.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society